PMID- 24513672 OWN - NLM STAT- Publisher LR - 20240228 IS - 1523-6536 (Electronic) IS - 1083-8791 (Linking) DP - 2013 Oct 25 TI - Donor selection for KIR B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation. LID - S1083-8791(13)00494-1 [pii] LID - 10.1016/j.bbmt.2013.10.017 [doi] AB - After hematopoietic stem cell transplantation (HSCT), natural killer (NK) cell alloreactivity in human leukocyte antigen (HLA) cell of recipients is regulated by killer immunoglobulin-like receptors (KIRs) on donor NK cells. The effect of KIRs on HSCT outcomes is controversial, particularly in those undergoing HLA-identical sibling HSCT. In this study, effects of KIR and HLA genotypes on the HSCT outcome were investigated in a 5-year retrospective study comprising 219 patient-donor pairs undergoing HLA-identical sibling HSCT for myeloid and lymphoid malignancies. We found that 39.7% (87/219) of these pairs who were KIR mismatched had better overall survival (OS) and reduced III-IV acute graft-versus-host disease (aGVHD), especially in acute myeloid leukemia (AML) patients. Bx1 donor KIR genotype with haplotype B on a telomeric region was a risk factor for the OS and relapse-free survival (RFS). Donor centromeric (c) and telomeric (t) KIR haplotype analysis showed that donor KIR cB-tA/tB was associated with improved OS and RFS compared with cA-tA or cA-tB. Furthermore, donor KIR B haplotype of the centromeric motifs (Cen-B) was an independent beneficial factor in improving OS and RFS and in protecting from relapse after HSCT. In AML patients, the occurrence of aGVHD was significantly lower in HLA-C1 group compared to that in HLA-C2 group, while such effect was not observed in patients with acute lymphoblastic leukemia or chronic myelogenous leukemia. Our results suggest that KIR could impact outcome and donor KIR haplotype with Cen-B confer significant survival benefits to HLA-identical sibling HSCT. CI - (c) 2013 American Society for Blood and Marrow Transplantation. FAU - Zhou, Huifen AU - Zhou H AD - Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. FAU - Bao, Xiaojing AU - Bao X AD - Department of HLA Laboratory, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. FAU - Wu, Xiaojin AU - Wu X AD - Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. FAU - Tang, Xiaowen AU - Tang X AD - Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. FAU - Wang, Miao AU - Wang M AD - Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. FAU - Wu, Depei AU - Wu D AD - Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. Electronic address: wudepei@medmail.com.cn. FAU - He, Jun AU - He J AD - Department of HLA Laboratory, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, P.R.China. Electronic address: junhe1964@163.com. LA - eng PT - Journal Article DEP - 20131025 PL - United States TA - Biol Blood Marrow Transplant JT - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation JID - 9600628 OTO - NOTNLM OT - Centromeric B OT - HSCT OT - KIR OT - haplotype OT - sibling EDAT- 2014/02/12 06:00 MHDA- 2014/02/12 06:00 CRDT- 2014/02/12 06:00 PHST- 2013/06/06 00:00 [received] PHST- 2013/10/20 00:00 [accepted] PHST- 2014/02/12 06:00 [entrez] PHST- 2014/02/12 06:00 [pubmed] PHST- 2014/02/12 06:00 [medline] AID - S1083-8791(13)00494-1 [pii] AID - 10.1016/j.bbmt.2013.10.017 [doi] PST - aheadofprint SO - Biol Blood Marrow Transplant. 2013 Oct 25:S1083-8791(13)00494-1. doi: 10.1016/j.bbmt.2013.10.017.